Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial

Taoyun Ji, Zhao Yang, Qingzhu Liu, Jianxiang Liao, Fei Yin, Yanhui Chen, Liping Zou, Baomin Li, Yuxing Gao, Xiaomei Shu, Shaoping Huang, Feng Gao, Jianmin Liang, Su Fang Lin, Jing Peng, Shiwei Song, Jing Wang, Chao Che, Wenxiu Sun, Maoqiang Tian, Lin Yang, Yi Hua, Yunpeng Hao, Lixin Cai, Luming Li, Yuwu Jiang, Taoyun Ji, Zhao Yang, Qingzhu Liu, Jianxiang Liao, Fei Yin, Yanhui Chen, Liping Zou, Baomin Li, Yuxing Gao, Xiaomei Shu, Shaoping Huang, Feng Gao, Jianmin Liang, Su Fang Lin, Jing Peng, Shiwei Song, Jing Wang, Chao Che, Wenxiu Sun, Maoqiang Tian, Lin Yang, Yi Hua, Yunpeng Hao, Lixin Cai, Luming Li, Yuwu Jiang

Abstract

Background: Recent clinical observations have reported the potential benefit of vagus nerve stimulation (VNS) as an adjunctive therapy for pediatric epilepsy. Preliminary evidence suggests that VNS treatment is effective for seizure reduction and mental development in young participants between 3 and 6 years of age who suffer from intractable epilepsy. However, robust clinical evidence for quantifying the difference of the efficacy and safety of VNS treatment in this specific patient population has yet to be reported.

Methods/design: A two-armed, multicenter, randomized, double-blind, prospective trial will be carried out to evaluate whether VNS is beneficial and safe for pediatric epilepsy. Pediatric participants aged between 3 to 6 years old with intractable epilepsy will be recruited and randomly assigned to experimental and control groups with a 1:1 allocation using a computer-generating randomization schedule. Before enrollment, informed consent will be signed by the parents of the participants and the study researchers. Participants in the experimental group will receive electrical stimulation over 24 weeks under standard stimulation parameters. Participants in the control group will not receive any stimulation during the 12 weeks of the double-blind period. The guardians of the participants are required to keep a detailed diary to record seizure activity. Outcome assessments including seizure frequency, Gesell Mental Developmental Scale scores, use of antiepileptic drugs and dosages, and adverse events will be collected at baseline, 6, 12, 18 and/or 24 weeks after electrical stimulation is initiated. The effects of treatment will be analyzed with time and treatment group comparisons.

Discussion: This trial will evaluate quantitative differences in efficacy and safety with/without VNS treatment for pediatric participants aged between 3 to 6 years with intractable epilepsy and will explore whether the current age range of VNS therapy can be expanded.

Trial registration: ClinicalTrials.gov, ID: NCT03062514 , Registered on 23 February 2017.

Keywords: Efficacy; Pediatric intractable epilepsy; Safety; Vagus nerve stimulation.

Conflict of interest statement

Ethics approval and consent to participate

The VNS-PIE study received ethical approval from the Clinical Trial Ethics Committee of Peking University First Hospital, covering all participating sites. Important changes to the protocol will be submitted to the Ethics Committee for review. Informed consent will be obtained from all participants in the trial.

Consent for publication

Consent forms for the trial include consent for publication of results in peer-reviewed journals.

Competing interests

Salary and grant supports in this trial are supported by the sponsor. No additional reporting is allowed until the final report of the trial is completed, with the exception of consent by the sponsor. Information on the sponsor’s and investigator’s publishing policies will be described in their clinical trial contract.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow chart of the VNS-PIE trial
Fig. 2
Fig. 2
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure for the VNS-PIE trial

References

    1. Moshé SL, et al. Epilepsy: new advances. Lancet. 2015;385(9971):884–898.
    1. Guerrini R. Epilepsy in children. Lancet. 2006;367(9509):499–524.
    1. Fisher RS, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) Epilepsia. 2005;46(4):470–472.
    1. Helmstaedter C, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54(4):425–432.
    1. Hirsch E, Schmitz B, Carreno M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand. 2003;108(s180):23–32.
    1. Jones JE, et al. Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: short-term outcomes. Epilepsy Behav. 2010;18(3):211–217.
    1. Hansen BH, et al. Sleep problems in children and adolescents with epilepsy: associations with psychiatric comorbidity. Epilepsy Behav. 2016;62:14–19.
    1. Austin Joan K, Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia. 2007;48(9):1639–1651.
    1. Agrawal N, Govender S. Epilepsy and neuropsychiatric comorbidities. Adv Psychiatr Treat. 2018;17(1):44–53.
    1. Bodin E, et al. Vagus nerve stimulation in the treatment of drug-resistant epilepsy in 29 children. Eur J Paediatric Neurol. 2016;20(3):346–351.
    1. Gurbani S, et al. Neuromodulation therapy with vagus nerve stimulation for intractable epilepsy: a 2-year efficacy analysis study in patients under 12 years of age. Epilepsy Res Treatment. 2016;2016:9709056.
    1. García-Pallero MA, et al. Effectiveness of vagal nerve stimulation in medication-resistant epilepsy. Comparison between patients with and without medication changes. Acta Neurochir. 2017;159(1):131–136.
    1. Schachter SC. Vagus nerve stimulation therapy summary five years after FDA approval. Neurology. 2002;59(6 suppl 4):S15–S29.
    1. FDA. 2017. Available from: . Accessed 2 Jan 2019.
    1. Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy. J Pediatr. 1999;134(5):563–566.
    1. Patwardhan RV, et al. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery. 2000;47(6):1353–1357.
    1. Helmers SL, et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol. 2001;16(11):843–848.
    1. Wheless JW, Maggio V. Vagus nerve stimulation therapy in patients younger than 18 years. Neurology. 2002;59(6 Suppl 4):S21–S25.
    1. Alexopoulos AV, et al. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006;15(7):491–503.
    1. Rossignol E, et al. Vagus nerve stimulation in pediatric epileptic syndromes. Seizure. 2009;18(1):34–37.
    1. Shahwan A, et al. Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction. Epilepsia. 2009;50(5):1220–1228.
    1. Elliott RE, et al. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr. 2011;7(5):491–500.
    1. Chen C-Y, et al. Short-term results of vagus nerve stimulation in pediatric patients with refractory epilepsy. Pediatr Neonatol. 2012;53(3):184–187.
    1. Thompson EM, et al. Vagus nerve stimulation for partial and generalized epilepsy from infancy to adolescence. J Neurosurg Pediatr. 2012;10(3):200–205.
    1. Klinkenberg S, et al. Behavioural and cognitive effects during vagus nerve stimulation in children with intractable epilepsy—a randomized controlled trial. Eur J Paediatr Neurol. 2013;17(1):82–90.
    1. Orosz I, et al. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia. 2014;55(10):1576–1584.
    1. Serdaroglu A, et al. Long term effect of vagus nerve stimulation in pediatric intractable epilepsy: an extended follow-up. Child’s Nervous Syst. 2016;32(4):641–646.
    1. Murphy JV, et al. Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center. Arch Pediatrics Adolesc Med. 2003;157(6):560–564.
    1. Benifla M, et al. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Child’s Nervous Syst. 2006;22(8):1018–1026.
    1. Zaaimi B, et al. Vagus nerve stimulation induces changes in respiratory sinus arrhythmia of epileptic children during sleep. Epilepsia. 2009;50(11):2473–2480.
    1. Connor DE, Jr, et al. Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. Neurosurg Focus. 2012;32(3):E12.
    1. Klinkenberg S. VNS in children: more than just seizure reduction. Netherlands: Maastricht University; 2015.
    1. Ulate-Campos A, et al. Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life. Neurol (English Edition) 2015;30(8):465–471.
    1. Colicchio G, et al. Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration. Childs Nerv Syst. 2010;26(6):811–819.
    1. Marques CM, et al. Cognitive decline in temporal lobe epilepsy due to unilateral hippocampal sclerosis. Epilepsy Behav. 2007;10(3):477–485.
    1. Caplan R, et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia. 2008;49(11):1838–1846.
    1. Høie B, et al. The combined burden of cognitive, executive function, and psychosocial problems in children with epilepsy: a population-based study. Dev Med Child Neurol. 2008;50(7):530–536.
    1. Verrotti A, et al. Neuropsychological impairment in childhood absence epilepsy: review of the literature. J Neurol Sci. 2015;359(1):59–66.
    1. Hermann BP, et al. Cognitive phenotypes in childhood idiopathic epilepsies. Epilepsy Behav. 2016;61:269–274.
    1. Sabaz M, et al. The impact of epilepsy surgery on quality of life in children. Neurology. 2006;66(4):557–561.
    1. Spencer SS, et al. Initial outcomes in the multicenter study of epilepsy surgery. Neurology. 2003;61(12):1680–1685.
    1. Kwan P, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077.
    1. Elliott RE, et al. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy & Behavior. 2011;20(3):478–483.
    1. Amar AP, Apuzzo MLJ, Liu CY. Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the Vagus Nerve Stimulation Therapy Patient Outcome Registry. Neurosurgery. 2004;55(5):1086–1093.
    1. Fisher R, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899–908.
    1. Boutron I, et al. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4(2):e61.
    1. Montavont A, et al. Efficacité de la stimulation intermittente du nerf vague dans les épilepsies pharmaco-résistantes non chirurgicales de l’adolescent et de l’adulte. Rev Neurol. 2007;163(12):1169–1177.
    1. Murphy JV, Hornig G, Schallert G. Left vagal nerve stimulation in children with refractory epilepsy. Preliminary observations. Arch Neurol. 1995;52(9):886–889.
    1. Hornig GW, et al. Left vagus nerve stimulation in children with refractory epilepsy: an update. South Med J. 1997;90(5):484–488.
    1. Lundgren J, et al. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia. 1998;39(8):809–813.
    1. Majoie HJM, et al. Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure. 2005;14(1):10–18.
    1. Klinkenberg S, et al. Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial. Dev Med Child Neurol. 2012;54(9):855–861.
    1. Klenberg L, Korkman M, Lahti-Nuuttila P. Differential development of attention and executive functions in 3-to 12-year-old Finnish children. Dev Neuropsychol. 2001;20(1):407–428.
    1. Handforth A, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51(1):48–55.
    1. You SJ, et al. Vagus nerve stimulation in intractable childhood epilepsy: a Korean multicenter experience. J Korean Med Sci. 2007;22(3):442–445.
    1. Lagae L. Cognitive side effects of anti-epileptic drugs. Seizure-Eur J Epilepsy. 2006;15(4):235–241.
    1. Terra VC, et al. Vagus nerve stimulation in pediatric patients: is it really worthwhile? Epilepsy Behav. 2014;31:329–333.
    1. Childhood Development. 2018. Available from: . Accessed 2 Jan 2019.
    1. Li B-M, et al. Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation. Epilepsy Behav. 2011;21(3):291–295.
    1. Liu SY, et al. Surgical treatment for epilepsy in 17 children with tuberous sclerosis-related West syndrome. Epilepsy Res. 2012;101(1–2):36–45.
    1. Zhu DN, et al. Therapeutic effect of ketogenic diet for refractory epilepsy in children: a prospective observational study. Chinese J Contemp Pediatrics. 2014;16(5):513–517.
    1. Xiang S, Li X, Feng X. Effects of focal interictal epileptiform discharges on cognitive development in children with cerebral palsy. Chinese J Rehabil Med. 2015;30(1):22–25.
    1. Nagarajan L, et al. VNS therapy in clinical practice in children with refractory epilepsy. Acta Neurol Scand. 2002;105(1):13–17.
    1. Ardesch J, et al. Vagus nerve stimulation for epilepsy activates the vocal folds maximally at therapeutic levels. Epilepsy Res. 2010;89(2–3):227–231.
    1. Malow B, et al. Effects of vagus nerve stimulation on respiration during sleep. A pilot study. Neurology. 2000;55(10):1450–1454.
    1. Hsieh T, et al. Sleep-related breathing disorder in children with vagal nerve stimulators. Pediatr Neurol. 2008;38(2):99–103.
    1. Murphy JV, et al. Adverse events in children receiving intermittent left vagal nerve stimulation. Pediatr Neurol. 1998;19(1):42–44.
    1. Spuck S, et al. Operative and technical complications of vagus nerve stimulator implantation. Operat Neurosurg. 2010;67(uppl_2):ons489–ons494.
    1. Sarkis RA, et al. Autonomic changes following generalized tonic clonic seizures: an analysis of adult and pediatric patients with epilepsy. Epilepsy Res. 2015;115:113–118.
    1. Morris GL, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453–1459.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren